Public annual accounts

CAREFUZE financials

A multi-period view of the public annual-account figures reported for CAREFUZE, with comparable measures and links to available source documents.

Company overview
Registry number

0726639173

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

2025 versus 2024

Operating line
€86,663

-6.4%

EBITDA
€83,132

-7%

Total assets
€316,789

+18.4%

Equity
€284,171

+25%

EBITDA margin +95.9% · Equity ratio +89.7%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202531 Dec 2025€86,663€83,132€316,789€284,171-
202431 Dec 2024€92,601€89,343€267,459€227,341-
Gross margin as filed under the abbreviated schema. This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report